MLLT10P1: A Pseudogene with Potential as A Drug Target Or Biomarker

Target Name: MLLT10P1

NCBI ID: G140678

MLLT10P1

Other Name(s): Myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10 pseudogene 1 | bA348I14.3 | MLLT10 pseudogene 1 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 pseudogene 1 | MLLT10L

MLLT10P1: A Pseudogene with Potential as A Drug Target Or Biomarker

MLLT10P1 is a protein that is expressed in various tissues of the human body, including the blood cells, the nervous system, and the gastrointestinal tract. It is a member of the MLL family of proteins, which are known for their role in the development and maintenance of hematopoietic stem cells. MLLT10P1 is also a pseudogene, which means that it is a gene that has been present in the human genome for a long time, but has not been expressed until recently.

MLLT10P1 is a protein that is expressed in various tissues of the human body, including the blood cells, the nervous system, and the gastrointestinal tract.

One of the unique features of MLLT10P1 is its ability to translocate to other pseudogenes, which are genes that have been present in the human genome for a long time, but have not been expressed until recently. This ability makes MLLT10P1 a potential drug target, or biomarker, because researchers can use it to study the effects of drugs on other genes that are expressed in the same way.

MLLT10P1 is also of interest because it is involved in the development and maintenance of hematopoietic stem cells. Hematopoietic stem cells are a type of stem cell that have the ability to develop into any type of blood cell in the body. MLLT10P1 plays a role in the development and maintenance of these stem cells, which may be important for understanding the mechanisms of hematopoietic stem cell development and the development of various diseases.

In addition to its role in hematopoietic stem cell development, MLLT10P1 is also involved in the regulation of cell signaling pathways. This is important because many diseases are caused by changes in the way that cells communicate with each other. By studying the role of MLLT10P1 in these signaling pathways, researchers may be able to develop new treatments for a variety of diseases.

Overall, MLLT10P1 is a protein that is of interest for many different reasons. Its ability to translocate to other pseudogenes and its involvement in the development and maintenance of hematopoietic stem cells make it a potential drug target or biomarker. Additionally, its role in cell signaling pathways may also make it a useful tool for studying the mechanisms of disease.

Protein Name: MLLT10 Pseudogene 1

The "MLLT10P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MLLT10P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets